Research Library

Baker Institute director Edward P. Djerejian comments on a welcome moment of nonpartisanship after the April 21, 2018, funeral for former first lady Barbara Bush. 

High cancer drug prices reduce access to therapy, cause treatment abandonment and financial bankruptcies, as well as severe emotional and family distress.

The 340B Drug Pricing Program, which allows uninsured or low-income patients to buy prescription drugs at discounted prices, is under attack.

In this commentary, the authors examine the roots of the United States’ reluctance to embrace universal health care, concluding that it "is neither sound nor ethical in a nation that promulgates fairness and equal opportunity" to deny coverage.

Contrasting perceptions of the real "winner" of of Iran nuclear deal may have disastrous regional implications.

In a July 5 referendum, Greeks overwhelmingly rejected the terms of a bailout proposed by international creditors. Baker Institute Rice scholar Ted Temzelides blogs on the surprisingly strong vote against the rescue package, and what may lie ahead.